🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ya-Lin A. Huang

Wellcome Sanger Institute

ORCID: 0000-0003-3137-8594
MedicineImmunology and MicrobiologyHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.1Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Trends in the Number and Characteristics of HIV Pre-Exposure Prophylaxis Providers in the United States, 2014–2019

JAIDS Journal of Acquired Immune Deficiency Syndromes(2021)10.1097/qai.0000000000002774
Top 18%
1.1DataRank
Top 18%20 citations

Ya-Lin A. Huang, Athena P. Kourtis, Karen W. Hoover, Weiming Zhu

Papers

Driven by 11 papers — median percentile 82. Top paper: “Trends in the Number and Characteristics of HIV Pre-Exposure Prophylaxis Providers in the United States, 2014–2019”.

Trends in the Number and Characteristics of HIV Pre-Exposure Prophylaxis Providers in the United States, 2014–2019

JAIDS Journal of Acquired Immune Deficiency Syndromes(2021)10.1097/qai.0000000000002774
Top 18%
1.1DataRank
Top 18%20 citations

Ya-Lin A. Huang, Athena P. Kourtis, Karen W. Hoover, Weiming Zhu

Human Immunodeficiency Virus and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010–2017

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa017
N/A
0.593DataRank · unranked
51 citations

Ya-Lin A. Huang, Weiming Zhu, Hope King, Brian R. Edlin, Karen W. Hoover +1 more

Impact of the coronavirus disease 2019 pandemic on prescriptions for antiretroviral drugs for HIV treatment in the United States, 2019–2021

AIDS(2022)10.1097/qad.0000000000003315
N/A
0.464DataRank · unranked
21 citations

Ya-Lin A. Huang, Jeffrey Wiener, Robyn Neblett-Fanfair, Athena P. Kourtis, H. Irene Hall +2 more

Restricting Access: A Secondary Analysis of Scope of Practice Laws and Pre-exposure Prophylaxis Prescribing in the United States, 2017

Journal of the Association of Nurses in AIDS Care(2021)10.1097/jnc.0000000000000275
N/A
0DataRank · unranked
31 citations

Jun Zhang, Deborah Gelaude, Ya-Lin A. Huang, Yuko Mizuno, Karen W. Hoover +1 more

Low Human Immunodeficiency Virus (HIV) Testing Rates and No HIV Preexposure Prophylaxis Prescribed Among Female Patients Diagnosed With a Sexually Transmitted Infection, 2017–2018

Obstetrics and Gynecology(2020)10.1097/aog.0000000000004148
N/A
0DataRank · unranked
7 citations

Ya-Lin A. Huang, Karen W. Hoover, Kirk D. Henny

National Trends in Drug Payments for HIV Preexposure Prophylaxis in the United States, 2014 to 2018

Annals of Internal Medicine(2020)10.7326/m20-0786
N/A
0DataRank · unranked
20 citations

Weiming Zhu, Ya-Lin A. Huang, Ram K. Shrestha, Karen W. Hoover, Nathan W. Furukawa

Dolutegravir and pregnancy outcomes including neural tube defects in the USA during 2008–20: a national cohort study

The Lancet HIV(2023)10.1016/s2352-3018(23)00108-x
N/A
0DataRank · unranked
32 citations

Weiming Zhu, Margaret A. Lampe, Ya-Lin A. Huang, Karen W. Hoover, Athena P. Kourtis

Real-world HIV RNA and Antigen/Antibody Testing Among People Who Use Long-acting Injectable Preexposure Prophylaxis

Clinical Infectious Diseases(2025)10.1093/cid/ciaf173
N/A
0DataRank · unranked
7 citations

Kevin P. Delaney, Ya-Lin A. Huang, Rupa Patel, Athena P. Kourtis, Karen W. Hoover +1 more

Limited Utility of HIV RNA Testing to Monitor Oral Preexposure Prophylaxis Use: A Real-World Cohort Study—United States, 2019–2023

Clinical Infectious Diseases(2025)10.1093/cid/ciaf230
N/A
0DataRank · unranked
2 citations

Kevin P. Delaney, Ya-Lin A. Huang, Rupa Patel, Athena P. Kourtis, Karen W. Hoover +1 more

Gaps in guideline adherence: evaluating HLA-B*57:01 screening for abacavir sensitivity and the implementation of evidence-based HIV care

Clinical Biochemistry(2025)10.1016/j.clinbiochem.2025.110992
N/A
0DataRank · unranked
1 citations

Xia Yang, Ya-Lin A. Huang, Kate Buchacz, Rex Astles, Jesse O’Shea +1 more

Quantifying the number of people who would benefit from HIV pre-exposure prophylaxis (PrEP) in the United States: a comparison of behavioral, acquisition-risk based, and economic metrics

medRxiv(2025)10.1101/2025.09.29.25336900
N/A
0DataRank · unranked
0 citations

Athena P. Kourtis, Yizhi Liang, Lijia Zheng, Teresa Puente, Ya-Lin A. Huang +8 more